Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol

Bibliographic Details
Main Author:	Maksim V. Storozhuk
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	cannabidiol neurological diseases epilepsy anxiety anxiolytic GABAA receptors
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2023.1131653/full

Similar Items

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
by: José A. Crippa, et al.
Published: (2018-09-01)

CANNABIDIOL IMPROVES LEARNING AND MEMORY AND EXERTS ANXIOLYTIC EFFECT IN EXPERIMENTAL STUDY
by: Maria Georgieva-Kotetarova, et al.
Published: (2022-02-01)

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
by: Serena Silvestro, et al.
Published: (2020-11-01)

The therapeutic potential of purified cannabidiol
by: Saoirse Elizabeth O’Sullivan, et al.
Published: (2023-06-01)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
by: Zuzanna Lubczyńska, et al.
Published: (2023-06-01)

Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
by: Muhammad Yousaf, et al.
Published: (2022-08-01)

Pharmacovigilance on cannabidiol as an antiepileptic agent
by: Ilaria Ammendolia, et al.
Published: (2023-02-01)

Cannabidiol, from Past to Present: a Review
by: Andra Popescu, Alexandra Dreanca, Orsolya Sarpataki, Mihai Cernea, Aurelia Jourdan, Ioan Marcus
Published: (2023-06-01)

Cannabidiol and epilepsy in Brazil: a current review
by: Carlos André Oshiro, et al.
Published: (2022-08-01)

The effect of cannabidiol on seizure features and quality of life in drug-resistant frontal lobe epilepsy patients: a triple-blind controlled trial
by: Seyyed Reza Ebadi, et al.
Published: (2023-07-01)

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
by: Paula Morales, et al.
Published: (2017-06-01)

Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome
by: Béatrice Desnous, et al.
Published: (2024-02-01)

Cannabidiol in Humans—The Quest for Therapeutic Targets
by: Stéphane Potvin, et al.
Published: (2012-05-01)

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
by: Serena Silvestro, et al.
Published: (2019-04-01)

Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps
by: Guilherme Diogo Silva, et al.
Published: (2020-10-01)

Survey of local cannabidiol use in parents of children with epilepsy in Thailand: the prevalence, perceptions, and knowledge
by: Monsicha Ngampoopun, et al.
Published: (2022-07-01)

Cannabidiol and Neurodevelopmental Disorders in Children
by: Keith A. Kwan Cheung, et al.
Published: (2021-05-01)

The Polypharmacological Effects of Cannabidiol
by: Jorge Castillo-Arellano, et al.
Published: (2023-04-01)

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
by: Rosa Maria Vitale, et al.
Published: (2021-05-01)

A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
by: Oluwadara Pelumi Omotayo, et al.
Published: (2024-03-01)

Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
by: Mariana Luz-Veiga, et al.
Published: (2023-01-01)

Neuroprotection of cannabidiol in epileptic rats: Gut microbiome and metabolome sequencing
by: Xiaoxiang Gong, et al.
Published: (2022-11-01)

∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
by: José Alexandre Crippa, et al.
Published: (2016-09-01)

Disposition of a single oral dose of a cannabidiol medication in healthy cats
by: Tom Jukier, et al.
Published: (2023-05-01)

Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
by: Marcin Ożarowski, et al.
Published: (2021-04-01)

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
by: Cecilia Zavala-Tecuapetla, et al.
Published: (2022-12-01)

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
by: Sinemyiz Atalay, et al.
Published: (2019-12-01)

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
by: María Rodríguez-Muñoz, et al.
Published: (2018-09-01)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
by: Gabriel A. Garcia, et al.
Published: (2022-07-01)

Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
by: Cheng T, et al.
Published: (2018-05-01)

Is cannabidiol (CBD) effective to ease separation anxiety?
by: Nobuo Masataka
Published: (2024-02-01)

Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)
by: Alexander C. S. Thomson, et al.
Published: (2024-04-01)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
by: Gustavo Gonzalez-Cuevas, et al.
Published: (2021-10-01)

Pharmacokinetics of cannabidiol-/cannabidiolic acid-rich hemp oil in juvenile cynomolgus macaques (Macaca fascicularis)
by: Tinika N. Johns, et al.
Published: (2023-11-01)

Evaluation of anxiety-like behaviors following ethanol withdrawal in mice: effects of cannabidiol
by: Letícia Pin Coltri, et al.
Published: (2020-07-01)

Regulation of GABAA and 5-HT Receptors Involved in Anxiolytic Mechanisms of Jujube Seed: A System Biology Study Assisted by UPLC-Q-TOF/MS and RT-qPCR Method
by: Liang Chen, et al.
Published: (2020-10-01)

Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy
by: Zsolt Gáll, et al.
Published: (2022-07-01)

Cannabidiol Treatment for Lennox-Gastaut Syndrome at a Single Tertiary Center in South Korea
by: Han Na Jang, et al.
Published: (2023-01-01)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
by: Luisa Rocha, et al.
Published: (2020-03-01)

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
by: Philippe A. Melas, et al.
Published: (2021-02-01)